Powell Industries: Unlikely To Deliver Alpha In 2025
Powell Industries continued to see strong orders activity across its business segments. Read more to see why I'm neutral on ...
Buffalo News1dOpinion
5 reasons to keep the federal tax credit for EVs | Los Angeles Times
President-elect Donald Trump‘s transition team is planning to eliminate a $7,500 electric vehicle tax credit that helps ...
Opinion
Fredericksburg.com1dOpinion
5 reasons to keep the federal tax credit for EVs | Los Angeles Times5 reasons to keep the federal tax credit for EVs | Los Angeles Times
President-elect Donald Trump‘s transition team is planning to eliminate a $7,500 electric vehicle tax credit that helps consumers afford clean cars while supporting the U.S. auto industry.
Pharmaceutical Technology1d
MET-3 by Nubiyota for Hypertriglyceridemia: Likelihood of Approval
MET-3 is under clinical development by Nubiyota and currently in Phase II for Hypertriglyceridemia. According to GlobalData, Phase II drugs for Hypertriglyceridemia have a 52% phase transition success ...
Pharmaceutical Technology1d
BG-102 by SL Bigen for Obesity: Likelihood of Approval
BG-102 is under clinical development by SL Bigen and currently in Phase II for Obesity. According to GlobalData, Phase II drugs for Obesity have a 29% phase transition success rate (PTSR) indication ...
Moderna: From Breakthrough COVID-19 Vaccines To Personalized Cancer Therapies
Moderna/Merck partnership and its potential in personalised cancer therapies are good opportunities for long-term investors.